Cantor Fitzgerald analyst Pamela Bassett upgraded Sequenom Inc. (Nasdaq: SQNM) to a Buy rating after the biotech settled a class action lawsuit lifting the stock price $1.13 to close at $8.05.
Sequenom Upgraded
March 02, 2010 at 16:22 PM EST
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.